The prognostic power of [ 11 C]methionine PET in IDH-wildtype diffuse gliomas with lower-grade histological features: venturing beyond WHO classification.

MLA

Ninatti, Gaia, et al. “The Prognostic Power of [ 11 C]Methionine PET in IDH-Wildtype Diffuse Gliomas with Lower-Grade Histological Features: Venturing beyond WHO Classification.” Journal of Neuro-Oncology, vol. 164, no. 2, Sept. 2023, pp. 473–81. EBSCOhost, https://doi.org/10.1007/s11060-023-04438-9.

APA

Ninatti, G., Pini, C., Bono, B. C., Gelardi, F., Antunovic, L., Fernandes, B., Sollini, M., Landoni, C., Chiti, A., & Pessina, F. (2023). The prognostic power of [ 11 C]methionine PET in IDH-wildtype diffuse gliomas with lower-grade histological features: venturing beyond WHO classification. Journal of Neuro-Oncology, 164(2), 473–481. https://doi.org/10.1007/s11060-023-04438-9

Chicago

Ninatti, Gaia, Cristiano Pini, Beatrice Claudia Bono, Fabrizia Gelardi, Lidija Antunovic, Bethania Fernandes, Martina Sollini, Claudio Landoni, Arturo Chiti, and Federico Pessina. 2023. “The Prognostic Power of [ 11 C]Methionine PET in IDH-Wildtype Diffuse Gliomas with Lower-Grade Histological Features: Venturing beyond WHO Classification.” Journal of Neuro-Oncology 164 (2): 473–81. doi:10.1007/s11060-023-04438-9.